Business Wire | Oct 8, 2020 04:05PM EDT

ResMed to Report First Quarter Fiscal 2021 Earnings on October 29, 2020

Oct. 08, 2020

SAN DIEGO--(BUSINESS WIRE)--Oct. 08, 2020--ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2021 on Thursday, October 29, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.

Earnings webcast details:

? Location: http://investor.resmed.com

? Date: Thursday, October 29, 2020

? Time: 1:30 p.m. PDT / 4:30 p.m. EDT

? International: London, Thursday, October 29, 8:30 p.m. GMT

Sydney, Friday, October 30, 7:30 a.m. AEDT

Please note that ResMed does not use outside phone lines to access the earnings call.

A replay of the earnings webcast will be accessible on ResMed's website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from October 29 until November 12 at:

* U.S.: +1 800.585.8367 * International: +1 416.621.4642 * Conference ID: 2192036

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201008005004/en/

CONTACT: For investors Amy Wakeham +1 858.836.5000 investorrelations@resmed.com

CONTACT: For media Jayme Rubenstein +1 858.836.6798 news@resmed.com